ANALYSIS/OPINION:
Kleon Tsetis, a restless pharmacist and researcher, with a vision to strengthen the position of Greek manufacturing in the pharmaceutical industry, established Uni-Pharma in 1963 with the mission to improve the quality of life of our fellow men by facilitating access to treatment with innovative, high-quality and cost-efficient pharmaceutical products. “Since its establishment, Uni-pharma has been active in research, development, manufacturing and marketing of pharmaceuticals of the highest quality, covering all major therapeutic areas, with innovative, ground-breaking products of their time, such as IV paracetamol, APOTEL and enteric-coated low-dose ASA, SALOSPIR, as well as technologically challenging products such as Levothyroxine Sodium, T4” explained Mrs. Julia Tseti, CEO of The Tsetis Pharmaceutical Group of Companies (OFET).